Immunai maps the immune system at single-cell resolution using machine learning to power therapeutic development and clinical trial optimization.
What it is
Immunai is an operating system and machine learning platform designed to map the human immune system at scale. By combining wet lab procedures with computational pipelines, the product analyzes clinical and preclinical samples to generate uniform single-cell data foundations. It integrates this data with AMICA, a large immune-focused database, to compute novel immune features, link mechanisms to treatment responses, and provide actionable recommendations for drug developers.
Key features
- Generate high-resolution multiomic data from clinical and preclinical samples
- Augment analysis using the AMICA single-cell database
- Compute novel immune features with machine learning models
- Validate hypotheses in the lab using functional genomics
- Optimize clinical trials by identifying patient populations and treatment strategies
Who it's for
Biopharmaceutical companies, research institutions, and organizations developing immune-related therapeutics and conducting clinical trials.
Pricing
Check the official website for current pricing.
Use cases
- Identify novel high impact targets linked to disease
- Prioritize promising drug candidates for preclinical development
- Stratify patient populations for clinical trials
Similar to Immunai
More Immunai alternatives
CARPL.ai
AnalyticsRadiology AI integration and validation platform
CARPL.ai is an enterprise imaging platform that unifies radiology workflows, offering a single integration pipeline for over 300 AI applications.
